Thermo Fisher Scientific | TMO - Pre Tax Profit


Thermo Fisher Scientific reported $1.73B in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Agilent USD 408M 44M Mar/2026
Becton, Dickinson and Co. USD 39M 354M Mar/2026
Bio Techne USD 106.09M 34.87M Jun/2026
Bio-Rad Laboratories USD 542.1M 1.23B Jun/2026
Boston Scientific USD 1.42B 261M Jun/2026
Bruker USD 117M 95.1M Jun/2026
Charles River Laboratories USD -29.94M 264.16M Mar/2026
Danaher USD 1.08B 157M Jun/2026
Dentsply International USD -42M 105M Mar/2026
Edwards Lifesciences USD 529.3M 90.4M Jun/2026
General Electric Aerospace USD 2.2B 654M Mar/2026
Henry Schein USD 137M 13M Jun/2026
Illumina USD 260M 103M Jun/2026
Intuitive Surgical USD 940.4M 15.2M Mar/2026
IQVIA Holdings USD 301M 5.92B Jun/2026
Laboratory Of America USD 8.61B 121.8M Jun/2026
Medtronic USD 2.45B 1.04B Mar/2026
Mettler Toledo International USD 209.66M 119.42M Mar/2026
Myriad Genetics USD 4.6M 3.4M Dec/2025
Olympus JPY 27.56B 484M Jun/2026
OraSure Technologies USD -18.43M 5.14M Dec/2025
Quest Diagnostics USD 334M 4M Mar/2026
Repligen USD 14.15M 12.38M Jun/2026
Revvity USD 187.24M 137.25M Jun/2026
Stryker USD 850M 855M Mar/2026
Thermo Fisher Scientific USD 1.73B 389M Mar/2026
Veracyte USD 26.52M 3.45M Jun/2026
Waters USD 356M 444M Jun/2026
Zimmer Biomet Holdings USD 487.5M 186.2M Jun/2026